Description: Facilitators lead a discussion of recent experiences and current issues regarding the valuation of medical and dental insurance and managed care products. Includes a discussion of deficiency reserves, HMO reserving, liquidity tests, cashflow testing and codification of regulations. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 132

Description: This 1991 panel discussion considers several valuation issues from the point of view of an actuary of an insurance Company, a Blue Cross/Blue Shield Plan, and a Health Maintenance Organization [HMO]. The issues discussed include basic methodology, source of data/coding conventions, extended benefit provision, loss adjustment expense, provider arrangements, employer refund arrangements and cash flow testing. From the Record of the Society of Actuaries Vol. 17, No. 3B.

Description: The panelists in this session discuss recent developments impacting the actuarial valuation of retiree health benefits. Topics include Medicare prescription drug reform, FAS 106, and proposed GASB statements. From the Record of the Society of Actuaries, Volume 30, No. 1, Session 19

Description: 1992 SOA Annual Meeting, Washington, D.C. This 1992 session on the Statutory Valuation Opinion covered the following topics: 1. Regulatory issues and the amendments to the standard valuation law. 2. Practical considerations, such as accumulating data, setting assumptions and creating models. 3. Issues and considerations involved in cash-flow testing.

Description: This session is about health insurance cash-flow testing through liability and asset modeling for individual disability income insurance and health valuations. From Record of Society of Actuaries Vol. 19, No. 1B.

Description: This session is about appraisals of blocks of health business: issues to consider, building a model, setting assumptions and ASB requirements. From Record of Society of Actuaries Vol. 19, No. 1A.

Description: Panelists address topics such as techniques for testing data quality, the actuary’s responsibility for verifying the reasonableness of data, and considerations in modifying data sources for specific situations. Included is a discussion of ASOP No. 23. From the Record of the Society of Actuaries, Volume 27, No. 1, Session 96

Description: This session discusses activities of the AAA with respect to financial reporting and actuarial opinions, related emerging legislation [Sarbanes-Oxley], FAS 141 & 142 [business combinations], and liability determination. From the Record of the Society of Actuaries, Volume 28, No. 3, Session 25

Description: 1993 SOA Spring Meeting, Boston. This session is about actuarial standards for product actuaries and Actuarial Standards Board guidelines review. Topics included: 1. ASP 12 on risk classification. 2. ASP 15 on Dividend determination and illustrations for participating life Insurance and annuities. 3. Determination and redetermination of nonguaranteed elements. 4. When to do cash-flow testing. 5. ASP 7 on performing cash-flow testing.

Description: In this session on the topic of health insurance valuation issues, the topics covered included Sarbanes-Oxley considerations, internal replacement Standards of Practice, self-funded plans, and long-term-care insurance developments. From a session at the Health/Pension Spring Meeting held in New Orleans, Louisiana June 15-17, 2005.